P

Inventor

KISELYOV ALEXANDER

US13 patents
⚠️ This page may combine multiple inventors who share the name “KISELYOV ALEXANDER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SINGH JASBIR

3 patents
US8791267B2Jul 29, 2014

Biaryl PDE4 inhibitors for treating inflammatory, cardiovascular and CNS disorders

SINGH JASBIR4 citations67
US8883833B2Nov 11, 2014

Substituted benzoazole PDE4 inhibitors for treating inflammatory, cardiovascular and CNS disorders

SINGH JASBIR1 citations48
US8877816B2Nov 4, 2014

4-(or 5-) substituted catechol derivatives

SINGH JASBIR0 citations40

AMGEN INC

2 patents
US6995162B2Feb 7, 2006

Substituted alkylamine derivatives and methods of use

AMGEN INC48 citations95
US6849639B2Feb 1, 2005

Integrin inhibitors and their methods of use

AMGEN INC19 citations83

SONIC MASTER LTD

2 patents
US11806343B2Nov 7, 2023

Inhibitors of DUX4 induction for regulation of muscle function

SONIC MASTER LTD0 citations52
US11065243B2Jul 20, 2021

Inhibitors of DUX4 induction for regulation of muscle function

SONIC MASTER LTD1 citations52

GENEA BIOCELLS USA HOLDINGS INC

2 patents
US11376257B2Jul 5, 2022

Generation of muscle lineage cells and therapeutic uses thereof

GENEA BIOCELLS USA HOLDINGS INC0 citations52
US10933068B2Mar 2, 2021

Modulators of DUX4 for regulation of muscle function

GENEA BIOCELLS USA HOLDINGS INC1 citations51

UNIV NEW YORK STATE RES FOUND

2 patents
US7649113B2Jan 19, 2010

Mono, di and tri cyclic compounds useful for lowering IgE concentrations

UNIV NEW YORK STATE RES FOUND0 citations44
US7425655B2Sep 16, 2008

Mono di & tri cyclic compounds useful for lowering IgE concentrations

UNIV NEW YORK STATE RES FOUND0 citations44

STC UNM

1 patent
US7875721B2Jan 25, 2011

Compounds for binding to ERα/β and GPR30, methods of treating disease states and conditions mediated through these receptors and identification thereof

STC UNM13 citations80

GENEA IP HOLDINGS PTY LTD

1 patent
US10258628B2Apr 16, 2019

Generation of muscle lineage cells and therapeutic uses thereof

GENEA IP HOLDINGS PTY LTD2 citations66